Tissium

France · Healthtech · Biotech · Enterprise software

Develops biomorphic programmable polymers that repair nerves and tissue without stitches

Funding history

2 rounds · 2 with disclosed amounts
AnnouncedRoundAmountInvestors
Series D+€30MCathay — Role not disclosedMérieux Développement — Role not disclosed
EIB financing facility≤€30MEuropean Investment Bank — Lead
Sourcestissium.com ↗